No Data
No Data
No Data
No Data
No Data
Walvax Biotechnology Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Walvax Biotechnology Co., Ltd. (SZSE:300142) missed earnings with its latest first-quarter results, disappointing overly-optimistic forecasters. The analysts look to have been far too optimistic
Simply Wall StApr 27 06:57
Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial
Walvax Biotechnology's (SHE:300142) unit, Beijing Weida Biotechnology, withdrew plans to conduct clinical trials for a vaccine for the new strain of COVID-19, according to a Thursday filing on the She
MT NewswiresApr 25 12:34
Express News | Watson Biotech: Net profit to mother fell 91.79% year-on-year in the first quarter
BreakingsApr 24 20:55
Express News | Watson Biology: End of clinical trials of recombinant novel coronavirus vaccine (chimpanzee adenovirus vector)
BreakingsApr 24 16:21
Watson Biotech (300142.SZ): Quarterly report to be disclosed on April 25
Gelonghui, April 23 | Watson Biotech (300142.SZ) said on the investor interactive platform that the company will disclose the 2024 quarterly report on April 25, 2024. For specific operating data, please refer to the regular report disclosed later.
Gelonghui FinanceApr 23 07:21
Watson Biotech (300142.SZ): Currently, the company's RQ3033 vaccine is actively applying for approval for marketing
Gelonghui, April 18 | Watson Biotech (300142.SZ) said on the investor interactive platform that currently the company's RQ3033 vaccine is actively applying for approval for listing (including conditional listing), but the exact timing is subject to regulatory approval. The company continues to monitor the mutation of the coronavirus strain and promotes the development of iterative products through immunogenic bridging and other methods in accordance with the overall deployment of the country. If approved for listing in the future (including conditional listing), it is expected to have a positive impact on the company's business performance.
Gelonghui FinanceApr 18 07:31
No Data
No Data